Costs of extended immune check point inhibitors treatment in advanced/metastatic lung cancer: Bundling of costs proposal.

被引：0
|
作者：
Guirgis, Helmy M. [1 ]
机构：
[1] Canc Free Fdn, Dana Point, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21738
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
    Shao, Jun
    Wang, Chengdi
    Ren, Pengwei
    Jiang, Yuting
    Tian, Panwen
    Li, Weimin
    BIOSCIENCE REPORTS, 2020, 40
  • [32] Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives
    Liu, Juan
    Wang, Yichao
    Song, Zhidu
    Zhang, Yukai
    BIOCHEMICAL PHARMACOLOGY, 2025, 233
  • [33] Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases
    Ocepek, Andreja
    RADIOLOGY AND ONCOLOGY, 2024, 58 (02) : 179 - 185
  • [34] Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
    Genova, Carlo
    Rossi, Giovanni
    Rijavec, Erika
    Biello, Federica
    Barletta, Giulia
    Tagliamento, Marco
    Grossi, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (05) : 573 - 585
  • [35] DNA METHYLTRANSFER ASE INHIBITOR SYNERGIZE WITH IMMUNE CHECK POINT INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
    Wang, X.
    Gao, H.
    Yu, J.
    Liu, D.
    Wang, M.
    Weinshilboum, R.
    Wang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S72 - S72
  • [36] Treatment patterns and healthcare costs among patients with advanced non-small-cell lung cancer
    Henk, Henry J.
    Ray, Saurabh
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 189 - 197
  • [37] THE MANAGEMENT AND COSTS OF LOCALLY ADVANCED OR METASTATIC ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN GREECE
    Kousoulakou, H.
    Boukovinas, I
    Georgoulias, V
    Kosmidis, P.
    Koumakis, G.
    Makrantonakis, P.
    Samantas, E.
    Syrigos, K.
    Krikelis, D.
    Markouri, A.
    Geitona, M.
    VALUE IN HEALTH, 2015, 18 (07) : A451 - A451
  • [38] Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review
    Quintana M.
    Toriz J.A.
    Novick D.
    Jones K.
    Botello B.S.
    Silva J.A.
    PharmacoEconomics - Open, 2018, 2 (2) : 191 - 201
  • [39] Immunotherapy-induced pneumonitis in non-small cell lung cancer patients: current concern in treatment with immune-check-point inhibitors
    Sun, Zongqiong
    Wang, Sheng
    Du, Hongdi
    Shen, Hailin
    Zhu, Jingfen
    Li, Yonggang
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 891 - 898
  • [40] Immunotherapy-induced pneumonitis in non-small cell lung cancer patients: current concern in treatment with immune-check-point inhibitors
    Zongqiong Sun
    Sheng Wang
    Hongdi Du
    Hailin Shen
    Jingfen Zhu
    Yonggang Li
    Investigational New Drugs, 2021, 39 : 891 - 898
12345